IQVIA Holdings Inc.
IQVStock
$210.49+31.16%52W
Market Cap$35.14B
P/E25.84x
Div yield—
Beta1.20
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-24.80%
Price vs S&P 500 (4W)14.83%
VGM Score55.36
Market Capitalization$35.14B
P/E Ratio (Annual)25.84x
Earnings Surprise History
Q1 262.90est. 2.85
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.19
4.19
4.10
4.03
Industry Peers — R&D — Physical Sciences(15)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IQVIQVIA Holdings Inc. | C | C | B | $210.49 |
| INCYIncyte Genomics Inc | C | A | B | $116.65 |
| MEDPMedpace Holdings, Inc. Common Stock | F | B | B | $537.92 |
| ICLRIcon Plc | C | C | B | $170.00 |
| CRLCharles River Laboratories International, Inc. | D | D | B | $229.16 |
| ABSIAbsci Corporation Common Stock | F | F | A | $8.23 |
| NRCNRC Health Common Stock | D | D | B | $21.94 |
| OABIOmniAb, Inc. Common Stock | D | C | B | $2.04 |
| MXCTMaxCyte, Inc. Common Stock | C | D | B | $1.35 |
| ONMDOneMedNet Corp Class A Common Stock | D | C | C | $0.69 |
| BIAFbioAffinity Technologies, Inc. Common Stock | A | F | F | $0.71 |
About
IQVIA provides outsourced clinical trial services and healthcare data analytics to the global pharmaceutical and healthcare industries. The company operates through two segments: Research & Development, offering late-stage clinical trials to pharmaceutical, medical device, and diagnostic companies; and Technology & Analytics, delivering aggregated data and analytics solutions to pharmaceutical firms, healthcare providers, payers, and policymakers.